A citation-based method for searching scientific literature

Assunta Melaccio, Lucia Ilaria Sgaramella, Alessandro Pasculli, Giovanna Di Meo, Angela Gurrado, Francesco Paolo Prete, Angelo Vacca, Roberto Ria, Mario Testini. Cancers (Basel) 2021
Times Cited: 3







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
100


BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.
Fei Li, Guangqi Chen, Chunjun Sheng, Aaron M Gusdon, Yueye Huang, Zhongwei Lv, Huixiong Xu, Mingzhao Xing, Shen Qu. Endocr Relat Cancer 2015
78
66

A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma.
Huy Gia Vuong, Uyen N P Duong, Ahmed M A Altibi, Hanh T T Ngo, Thong Quang Pham, Hung Minh Tran, Greta Gandolfi, Lewis Hassell. Endocr Connect 2017
41
66

Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.
Seong-Keun Yoo, Seungbok Lee, Su-Jin Kim, Hyeon-Gun Jee, Byoung-Ae Kim, Hyesun Cho, Young Shin Song, Sun Wook Cho, Jae-Kyung Won, Jong-Yeon Shin,[...]. PLoS Genet 2016
176
66

Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
Annukka Heikkilä, Jaana Hagström, Hanna Mäenpää, Johanna Louhimo, Päivi Siironen, Ilkka Heiskanen, Caj Haglund, Johanna Arola. Thyroid 2013
20
66

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
191
66

Prognostic value of p27 in follicular thyroid carcinoma and its relation to radioactive iodine response: does it aid in the modification of risk stratification?
Magdy Hassan Kotb, Ahmed Mohamed Zaher, Mai Amr Abd El-Wahab, Iman Loay Hussein Abulkheir, Manar Hussein, Shahenda Sabry Salem. Appl Immunohistochem Mol Morphol 2014
1
100

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
33

Epithelial-mesenchymal transition and its implications for fibrosis.
Raghu Kalluri, Eric G Neilson. J Clin Invest 2003
33

ER-alpha and ER-beta expression in differentiated thyroid cancer: relation with tumor phenotype across the TNM staging and peri-tumor inflammation.
Flavia Magri, Valentina Capelli, Margherita Gaiti, Laura Villani, Francesca Zerbini, Luigi La Manna, Mario Rotondi, Luca Chiovato. Endocrine 2015
9
33

A central role for cadherin signaling in cancer.
Antonis Kourtidis, Ruifeng Lu, Lindy J Pence, Panos Z Anastasiadis. Exp Cell Res 2017
144
33

Molecular mechanisms of blood vessel growth.
E M Conway, D Collen, P Carmeliet. Cardiovasc Res 2001
682
33


P53 and expression of immunological markers may identify early stage thyroid tumors.
Marjory Alana Marcello, Elaine Cristina Morari, Lucas Leite Cunha, Aline Carolina De Nadai Silva, Dirce Maria Carraro, André Lopes Carvalho, Fernando Augusto Soares, José Vassallo, Laura Sterian Ward. Clin Dev Immunol 2013
16
33

Survivin: A molecular biomarker in cancer.
Praveen Kumar Jaiswal, Apul Goel, R D Mittal. Indian J Med Res 2015
166
33

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.
Nikhil Gupta, Anil K Dasyam, Sally E Carty, Marina N Nikiforova, N Paul Ohori, Michaele Armstrong, Linwah Yip, Shane O LeBeau, Kelly L McCoy, Christopher Coyne,[...]. J Clin Endocrinol Metab 2013
100
33

RAS mutations in thyroid cancer.
Gina M Howell, Steven P Hodak, Linwah Yip. Oncologist 2013
107
33

Prognostic value of oncoprotein expressions in thyroid papillary carcinoma.
A Z Balta, A I Filiz, Y Kurt, I Sucullu, E Yucel, M L Akin. Med Oncol 2012
19
33

BRAF-mutated carcinomas among thyroid nodules with prior indeterminate FNA report: a systematic review and meta-analysis.
Pierpaolo Trimboli, Giorgio Treglia, Emma Condorelli, Francesco Romanelli, Anna Crescenzi, Massimo Bongiovanni, Luca Giovanella. Clin Endocrinol (Oxf) 2016
37
33

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression.
Brian Keith, Randall S Johnson, M Celeste Simon. Nat Rev Cancer 2011
33


Estrogen and cancer.
Jing Liang, Yongfeng Shang. Annu Rev Physiol 2013
159
33

Application of immunohistochemistry in thyroid pathology.
Haiyan Liu, Fan Lin. Arch Pathol Lab Med 2015
44
33

Evaluation of MMP2 and Caspase-3 expression in 107 cases of papillary thyroid carcinoma and its association with prognostic factors.
Hiva Saffar, Sanaz Sanii, Binesh Emami, Ramin Heshmat, Vahid Hagh Panah, Sima Azimi, Seyed Mohammad Tavangar. Pathol Res Pract 2013
18
33


CD44 as a tumor biomarker and therapeutic target.
Hanxiao Xu, Mengke Niu, Xun Yuan, Kongming Wu, Aiguo Liu. Exp Hematol Oncol 2020
55
33

Estrogen and its receptors in cancer.
George G Chen, Qiang Zeng, Gary Mk Tse. Med Res Rev 2008
141
33

BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis.
Guillaume Gauchotte, Christophe Philippe, Stéphanie Lacomme, Brigitte Léotard, Marie-Pierre Wissler, Lila Allou, Bruno Toussaint, Marc Klein, Jean-Michel Vignaud, Aude Bressenot. Pathology 2011
39
33

Clinical prognostic significance of cancer stem cell markers in patients with papillary thyroid carcinoma.
Yoon-Jong Ryu, Ji-Young Choe, Kyoungyul Lee, Soon-Hyun Ahn. Oncol Lett 2020
4
33

p27 as Jekyll and Hyde: regulation of cell cycle and cell motility.
Michelle D Larrea, Seth A Wander, Joyce M Slingerland. Cell Cycle 2009
105
33


Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, David Viola, Rossella Elisei, Bela Bendlova, Linwah Yip, Caterina Mian, Federica Vianello, R Michael Tuttle,[...]. JAMA 2013
577
33

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma.
Cristina Romei, Rossella Elisei. Front Endocrinol (Lausanne) 2012
83
33

A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.
R K Moyzis, J M Buckingham, L S Cram, M Dani, L L Deaven, M D Jones, J Meyne, R L Ratliff, J R Wu. Proc Natl Acad Sci U S A 1988
33



BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
Carol Li, Kathleen C Lee, Eric B Schneider, Martha A Zeiger. J Clin Endocrinol Metab 2012
177
33

Estrogen receptor subtype expression and regulation is altered in papillary thyroid cancer after menopause.
Gustavo A Rubio, Paola Catanuto, Marilyn K Glassberg, John I Lew, Sharon J Elliot. Surgery 2018
17
33

BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma.
Anna Guerra, Vincenzo Marotta, Maurilio Deandrea, Manuela Motta, Paolo Piero Limone, Alessia Caleo, Pio Zeppa, Silvano Esposito, Franco Fulciniti, Mario Vitale. Endocrine 2013
25
33


VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis.
Andrew V Benest, Steven J Harper, Seppo Yla Herttuala, Kari Alitalo, David O Bates. Cardiovasc Res 2008
57
33


Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?
Erik W Thompson, Donald F Newgreen, David Tarin. Cancer Res 2005
518
33

Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer.
George G Chen, Alexander C Vlantis, Qiang Zeng, C Andrew van Hasselt. Curr Cancer Drug Targets 2008
109
33

HIF-1α pathway: role, regulation and intervention for cancer therapy.
Georgina N Masoud, Wei Li. Acta Pharm Sin B 2015
850
33

Immunohistochemical expression and prognostic significance of VEGF-C in well-differentiated thyroid cancer.
S Ceric, T Ceric, N Pojskic, N Bilalovic, J Musanovic, E Kucukalic-Selimovic. Acta Endocrinol (Buchar) 2020
1
100



Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond.
Maria E Cabanillas, Mabel Ryder, Camilo Jimenez. Endocr Rev 2019
94
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.